raltitrexed (Compound)

Synonyms:Raltitrexed, Tomudex, 112887-68-0, ZD1694, ZD-1694, ICI-D1694, D-1694, D1694, ICI D1694, ZD-16, CHEBI:5847, (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid, Raltitrexed (Tomudex), FCB9EGG971, ZD 1694, CHEMBL225071, N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid, DTXSID0046482, ICI-D-1694, NSC-639186, N-(5-(((3,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thenoyl)-L-glutamic acid, NCGC00229704-01, (2S)-2-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid, (S)-2-(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)-methyl)amino)thiophene-2-carboxamido)pentanedioic acid, (S)-2-(5-(methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid, L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-, N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic acid, DTXCID8026482, (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid, D16, Tomudex (TN), D 1694, CAS-112887-68-0, UNII-FCB9EGG971, Raltitrexed (JAN/USAN/INN), 1hvy, 2kce, 2tsr, ZN-D1694, KS-5069, ZD1694; Raltitrexed, RALTITREXED [MI], RALTITREXED [INN], RALTITREXED [JAN], RALTITREXED [USAN], SCHEMBL7438, RALTITREXED [MART.], RALTITREXED [WHO-DD], MLS001424225, MLS006010125, Raltitrexed [USAN:INN:BAN], GTPL7403, BDBM18795, 1i00, HMS2052I03, HMS3715P08, (S)-2-(5-(methyl((2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid, AMY42113, N-(5-(N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;(S)-2-(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid, Tox21_112237, BDBM50027655, MFCD00864168, NSC639186, s1192, AKOS015894877, AKOS015994729, Tox21_112237_1, CCG-101075, CCG-221273, DB00293, NC00325, NCGC00263534-02, HY-10821, L-Glutamic acid, N-[[5-[[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-, NCI60_013008, SMR000469217, SMR002529608, BCP0726000267, R0208, SW197705-2, D01064, AB00698356-05, EN300-27032179, SR-01000763351, J-524216, SR-01000763351-3, BRD-K89839824-001-01-2, Q15304877, N-[[5-[[(1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid

Pubchem:PUBCHEM:104758

Id:062f7591-6a61-51a4-93b5-b08dbd0080f2

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View raltitrexed's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for raltitrexed.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with raltitrexed.

Results found

Linked to

	Label	Description
	BRD-K89839824-001-05-3 Substance (Entity type)	A Substance
	DCSTRUCT ID 02353 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02353; PubChem_CID:135400182, FILE=drugcentral_drug_02353.json)
	raltitrexed (ff14f3bf-7ca5-4f44-8276-12a16061e449) Collection (Entity type)	Metadatata for raltitrexed
	raltitrexed negatively regulates TLN1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	raltitrexed positively regulates DDB2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	raltitrexed negatively regulates VPS28 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	(1S,3'R,4'S,5'S,6'R)-6-[(4-Ethylphenyl)methyl]-6'-(hydroxymethyl)-3',4',5',6'-tetrahydro-3H-spiro[2-benzofuran-1,2'-pyran]-3',4',5'-triol in similarity relationship with raltitrexed Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	raltitrexed positively regulates TNFRSF10B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	raltitrexed positively regulates CDKN1A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	raltitrexed in similarity relationship with Mitomycin-c Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K89839824-001-05-3

Substance (Entity type)

A Substance

DCSTRUCT ID 02353

Collection (Entity type)

DrugPage Collection: (DrugCentralID:02353; PubChem_CID:135400182, FILE=drugcentral_drug_02353.json)

raltitrexed (ff14f3bf-7ca5-4f44-8276-12a16061e449)

Collection (Entity type)

Metadatata for raltitrexed

raltitrexed negatively regulates TLN1

Knowledge Graph Assertion (Entity type)